Literature DB >> 33602163

Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.

Yew Li Dang1, Hong Kuan Kok2,3, Penelope A McKelvie4, Matthew Ligtermoet5,6, Laura Maddy7, David A Burrows2, Douglas E Crompton5,8.   

Abstract

BACKGROUND: Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a neuro-inflammatory syndrome first described in 2010. It has a relationship with lymphoproliferative disorders that has not been fully elucidated. This case represents an unusual progression of CLIPPERS to Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis (LYG). The exact connection between CLIPPERS and LYG remains poorly understood. CASE
PRESENTATION: We present a case of a 75-year-old man who was diagnosed with CLIPPERS with initial response to immunosuppression but later progressed to EBV-related LYG. EBV polymerase chain reaction (PCR) was detected in his cerebrospinal fluid (CSF), and repeat imaging revealed findings that were uncharacteristic for CLIPPERS; thereby prompting a brain biopsy which led to a diagnosis of EBV-related LYG. This case highlights the following learning points: 1) CLIPPERS cases are often part of a spectrum of lymphomatous disease, 2) CLIPPERS can be associated with EBV-related lymphoproliferative disorders such as LYG, and 3) EBV detection in CSF should prompt earlier consideration for brain biopsy in patients.
CONCLUSIONS: Our case highlights the difficulty in distinguishing CLIPPERS from other steroid-responsive conditions such as neoplastic and granulomatous diseases. Given the association of CLIPPERS with EBV-related LYG as demonstrated in this case, we recommend testing for EBV in CSF for all patients with suspected CLIPPERS. An early referral for brain biopsy and treatment with rituximab should be considered for patients with suspected CLIPPERS who test positive for EBV in their CSF.

Entities:  

Keywords:  CLIPPERS; Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids; EBV; Epstein-Barr Virus; LYG; Lymphoma; Lymphomatoid granulomatosis

Mesh:

Substances:

Year:  2021        PMID: 33602163      PMCID: PMC7890986          DOI: 10.1186/s12883-021-02110-1

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  14 in total

1.  Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients.

Authors:  Guillaume Taieb; Claire Duflos; Dimitri Renard; Bertrand Audoin; Elsa Kaphan; Jean Pelletier; Nadège Limousin; Christine Tranchant; Stephane Kremer; Jérome de Sèze; Romain Lefaucheur; David Maltête; David Brassat; Michel Clanet; Patrice Desbordes; Eric Thouvenot; Laurent Magy; Thierry Vincent; Jean-Luc Faillie; Nicolas de Champfleur; Giovanni Castelnovo; Sandrine Eimer; Dominique Figarella Branger; Emmanuelle Uro-Coste; Pierre Labauge
Journal:  Arch Neurol       Date:  2012-07

2.  CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

Authors:  Guillaume Taieb; Patricia Mulero; Dimitri Psimaras; Bob W van Oosten; Jörg D Seebach; Romain Marignier; Fernando Pico; Valérie Rigau; Yuji Ueno; Claire Duflos; Vera Fominykh; Vincent Guiraud; Christine Lebrun-Frénay; Jean-Philippe Camdessanché; Philippe Kerschen; Guido Ahle; Nieves Téllez; Alex Rovira; Khe Hoang-Xuan; Jean Pelletier; Pierre Labauge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-05-09       Impact factor: 10.154

Review 3.  Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update.

Authors:  Sherif A Rezk; Xiaohui Zhao; Lawrence M Weiss
Journal:  Hum Pathol       Date:  2018-06-06       Impact factor: 3.466

4.  A central nervous system B-cell lymphoma arising two years after initial diagnosis of CLIPPERS.

Authors:  Guillaume Taieb; Emmanuelle Uro-Coste; Michel Clanet; Hans Lassmann; Alexandra Benouaich-Amiel; Camille Laurent; Marie-Bernadette Delisle; Pierre Labauge; David Brassat
Journal:  J Neurol Sci       Date:  2014-06-18       Impact factor: 3.181

Review 5.  Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.

Authors:  Christopher Melani; Elaine S Jaffe; Wyndham H Wilson
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

6.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): A lymphocytic reactive response of the central nervous system? A case report.

Authors:  Xiaolin Wang; Dehui Huang; Xusheng Huang; Jiatang Zhang; Ye Ran; Xin Lou; Qiuping Gui; Shengyuan Yu
Journal:  J Neuroimmunol       Date:  2017-01-26       Impact factor: 3.478

Review 7.  Lymphomatoid granulomatosis: insights gained over 4 decades.

Authors:  Anna-Luise A Katzenstein; Erika Doxtader; Sonia Narendra
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

8.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  Sean J Pittock; Jan Debruyne; Karl N Krecke; Caterina Giannini; Jelle van den Ameele; Veerle De Herdt; Andrew McKeon; Robert D Fealey; Brian G Weinshenker; Allen J Aksamit; Bruce R Krueger; Elizabeth A Shuster; B Mark Keegan
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

9.  Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  W Oliver Tobin; Yong Guo; Karl N Krecke; Joseph E Parisi; Claudia F Lucchinetti; Sean J Pittock; Jay Mandrekar; Divyanshu Dubey; Jan Debruyne; B Mark Keegan
Journal:  Brain       Date:  2017-09-01       Impact factor: 13.501

10.  A case of diffuse large B cell lymphoma initially presenting as CLIPPERS: possible role of the Epstein-Barr virus.

Authors:  June Woo Ahn; Ji Yun Jeong; Sung Kyoo Hwang; Ha Young Shin; Jin-Sung Park
Journal:  Neurol Sci       Date:  2020-09-29       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.